沃森生物：公司在研疫苗的研发若有实质性和阶段性进展公司会及时披露

Group 1 - The core point of the article is that Watson Bio is currently in the III phase of clinical research for its nine-valent HPV vaccine and will disclose any substantial and phase-related progress in its vaccine development in a timely manner [2]